Home › Compare › AAIRF vs ABBV
AAIRF yields 6060.61% · ABBV yields 3.06%● Live data
📍 AAIRF pulled ahead of the other in Year 1
Combined, AAIRF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AAIRF + ABBV for your $10,000?
American Aires Inc., a nanotechnology company, engages in the research, development, production, distribution, and sale of proprietary silicon-based microprocessors to protect persons from the harmful effects of electromagnetic radiation that are emitted by electronic devices in Canada. Its products include the Lifetune One, which reduce the effects of electromagnetic radiation emitted by data-transmitting electronics, such as cell phones, wireless earpieces, wireless headsets, laptops, monitors, baby monitors, Wi-Fi routers, and others; and the Lifetune Zone Max that protects large space from the effects of electromagnetic radiation emitted by data-transmitting devices found in any home, office, and vehicle. The company also offers the Lifetune Go and Lifetune Zone, that protects from the effects of electromagnetic radiation emitted by nearby electronic devices and electromagnetic smog. American Aires Inc. was incorporated in 2012 is based in Vaughan, Canada.
Full AAIRF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.